- District 17
Provides that the office of the attorney general, or an independent auditor with experience auditing expenses related to prescription drugs that is hired through a request for proposal process by the attorney general, shall conduct an audit concerning prescription drug costs for the Medicaid program. Requires the auditor to examine cost sharing, spread pricing, patient steering, proper brand and generic definitions, effective rate clawbacks, medical loss ratio inflation, formulary compliance, discriminatory pricing, and any other metric determined by the attorney general. Provides that the audit look back period for the initial audit must be the previous five state fiscal years. Provides that the audit look back period for every audit conducted thereafter must be the previous three state fiscal years. Provides that the results of an audit must be provided to the legislative council.
First reading: referred to Committee on Public Health
Referred to the House
Third reading: passed; Roll Call 193: yeas 49, nays 0
Cosponsors: Representatives Vermilion A and Carbaugh
House sponsor: Representative Lehman
Second reading: ordered engrossed
Senator Charbonneau added as second author
Committee report: amend do pass, adopted
Senator Randolph added as coauthor
Committee report: amend do pass adopted; reassigned to Committee on Appropriations
Authored by Senator Zay
First reading: referred to Committee on Insurance and Financial Institutions
|Bill Text Versions||Format|
|Introduced Senate Bill (S)|
|Senate Bill (S)|
|Senate Bill (S)|
|Fiscal Note: SB0318.03.COMS.FN001|
|Fiscal Note: SB0318.03.COMS.FN002|
|Fiscal Note: SB0318.03.COMS.FN003|
Data on Open States is updated periodically throughout the day from the official website of the Indiana General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.